CompletedNot Applicable

The Results of the Mediterranean Diet for PCOS

Turkey (Türkiye)98 participantsStarted 2024-09-20

Plain-language summary

The aim was to evaluate the effects of the application of a Mediterranean diet on the reproductive and metabolic parameters in the 3rd month in patients with a body mass index of 25 and more who were followed up in our clinic due to a PCOS diagnosis.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Age \< 18 and \> 40 years;
✕. Menopause, pregnancy or breastfeeding in the last 6 months;
✕. Hyperandrogenism and/or biochemical hyperandrogenemia due to secondary etiologies, including congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, thyroid dysfunction and adrenal disorders),
✕. Pre-existing systemic or psychiatric disease
✕. Use of drugs that affect carbohydrate or lipid metabolism (oral contraceptive pills, metformin, anti-epileptics, antipsychotics, statins and fish oil);
✕. Certain eating regimens or hypocaloric diet in the last three months; supplementing with antioxidants, vitamins or minerals;
✕. Non-steroidal anti-inflammatory drugs, diuretics, etc. use of medications that may affect fluid balance
✕. Female patients with implanted pacemakers or defibrillators due to the theoretical possibility of interference with device activity.

What they're measuring

the effect of applying a Mediterranean diet on Homa-IR in PCOS

Timeframe: 3 months

PREDIMED in PCOS

Timeframe: 3 months

the effect of applying a Mediterranean diet on glucose in PCOS

Timeframe: 3 months

the effect of applying a Mediterranean diet on HbA1c in PCOS

Timeframe: 3 months

Trial details

NCT IDNCT06442189

SponsorEtlik Zubeyde Hanım Women's Health Care, Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-07

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Age \< 18 and \> 40 years;
✕. Menopause, pregnancy or breastfeeding in the last 6 months;
✕. Hyperandrogenism and/or biochemical hyperandrogenemia due to secondary etiologies, including congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, thyroid dysfunction and adrenal disorders),
✕. Pre-existing systemic or psychiatric disease
✕. Use of drugs that affect carbohydrate or lipid metabolism (oral contraceptive pills, metformin, anti-epileptics, antipsychotics, statins and fish oil);
✕. Certain eating regimens or hypocaloric diet in the last three months; supplementing with antioxidants, vitamins or minerals;
✕. Non-steroidal anti-inflammatory drugs, diuretics, etc. use of medications that may affect fluid balance
✕. Female patients with implanted pacemakers or defibrillators due to the theoretical possibility of interference with device activity.